A dual drug regimen synergistically blocks human parainfluenza virus infection. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Scientific Reports Year : 2016

A dual drug regimen synergistically blocks human parainfluenza virus infection.

Abstract

Human parainfluenza type-3 virus (hPIV-3) is one of the principal aetiological agents of acute respiratory illness in infants worldwide and also shows high disease severity in the elderly and immunocompromised, but neither therapies nor vaccines are available to treat or prevent infection, respectively. Using a multidisciplinary approach we report herein that the approved drug suramin acts as a non-competitive in vitro inhibitor of the hPIV-3 haemagglutinin-neuraminidase (HN). Furthermore, the drug inhibits viral replication in mammalian epithelial cells with an IC50 of 30 μM, when applied post-adsorption. Significantly, we show in cell-based drug-combination studies using virus infection blockade assays, that suramin acts synergistically with the anti-influenza virus drug zanamivir. Our data suggests that lower concentrations of both drugs can be used to yield high levels of inhibition. Finally, using NMR spectroscopy and in silico docking simulations we confirmed that suramin binds HN simultaneously with zanamivir. This binding event occurs most likely in the vicinity of the protein primary binding site, resulting in an enhancement of the inhibitory potential of the N-acetylneuraminic acid-based inhibitor. This study offers a potentially exciting avenue for the treatment of parainfluenza infection by a combinatorial repurposing approach of well-established approved drugs.
Fichier principal
Vignette du fichier
srep24138.pdf (1.54 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-01302307 , version 1 (14-04-2016)

Licence

Attribution

Identifiers

Cite

Benjamin Bailly, Larissa Dirr, Ibrahim M El-Deeb, Ralf Altmeyer, Patrice Guillon, et al.. A dual drug regimen synergistically blocks human parainfluenza virus infection.. Scientific Reports, 2016, 6 (24138), pp.24138. ⟨10.1038/srep24138⟩. ⟨pasteur-01302307⟩

Collections

RIIP
118 View
237 Download

Altmetric

Share

Gmail Facebook X LinkedIn More